{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T20:41:22Z","timestamp":1712522482014},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ygyno.2011.04.049","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T08:47:36Z","timestamp":1308473256000},"page":"372-376","source":"Crossref","is-referenced-by-count":4,"title":["Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium"],"prefix":"10.1016","volume":"122","author":[{"given":"A.K.","family":"Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Asplund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hellberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.04.049_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygeno.2004.01.013","article-title":"The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea","volume":"84","author":"Guo","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1006\/bbrc.2001.5092","article-title":"Cloning, characterization, and expression of human LIG1","volume":"284","author":"Nilsson","year":"2001","journal-title":"Biochem Biophys Res Communications"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00441-003-0697-1","article-title":"LRIG1 protein in human cells and tissues","volume":"312","author":"Nilsson","year":"2003","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/028418602760169398","article-title":"Is LRIG1 a tumour suppressor gene at chromosome 3p14.3?","volume":"41","author":"Hedman","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0025","doi-asserted-by":"crossref","first-page":"47050","DOI":"10.1074\/jbc.M409703200","article-title":"The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases","volume":"279","author":"Laederich","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0030","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1038\/sj.emboj.7600342","article-title":"LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation","volume":"23","author":"Gur","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.bjc.6601208","article-title":"LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT-PCR and immunohistochemical analysis","volume":"89","author":"Thomasson","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ejca.2006.10.021","article-title":"LRIG inhibitors of growth factor signalling \u2014 double-edged swords in human cancer?","volume":"43","author":"Hedman","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1525-1438.2007.01021.x","article-title":"LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking","volume":"18","author":"Lindstr\u00f6m","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00401-006-0032-5","article-title":"Perinuclear leucine-rich repeats and immunoglobuline-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors","volume":"111","author":"Guo","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1524-4725.2005.31108","article-title":"LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases","volume":"31","author":"Tanemura","year":"2005","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.ygyno.2011.04.049_bb0060","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3109\/0284186X.2010.492789","article-title":"LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix","volume":"49","author":"Hedman","year":"2010","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1789.2008.00970.x","article-title":"Cytoplasmic LRIG2 expression is associated with poor oligidendroglioma patient survival","volume":"29","author":"Holmlund","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0070","first-page":"313","article-title":"Crum CP The binucleate squamous cell: histologic spectrum and relationship to low-grade squamous intraepithelial lesions","volume":"6","author":"Prasad","year":"1993","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0075","unstructured":"Sternberg's diagnostic surgical pathology vol 2, Fourth edition. 2005; 2377\u20132392."},{"key":"10.1016\/j.ygyno.2011.04.049_bb0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1074\/mcp.R500009-MCP200","article-title":"Antibody-based proteomics for human tissue profiling","volume":"4","author":"Uhlen","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0085","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1158\/0008-5472.CAN-07-6316","article-title":"Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer","volume":"68","author":"Miller","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0090","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1158\/1055-9965.EPI-09-0349","article-title":"Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma","volume":"18","author":"Sheu","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/bcr2248","article-title":"Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer","volume":"11","author":"Ljuslinder","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00432-009-0751-9","article-title":"Fragile histidine triad protein: structure, function and its association with tumorogenesis","volume":"136","author":"Hassan","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0105","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/1097-0142(19941015)74:8<2314::AID-CNCR2820740816>3.0.CO;2-1","article-title":"Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix","volume":"74","author":"van Bommel","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0110","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ygyno.2006.07.043","article-title":"The expressions of the Rb pathway in cervical intraepithelial neoplasia: predictive and prognostic significance","volume":"104","author":"Nam","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0120","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00018-009-8631-7","article-title":"The regulation of cell proliferation by the papillomavirus early proteins","volume":"66","author":"Hamid","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2559.2002.01343.x","article-title":"Ki67 protein: the immaculate deception?","volume":"40","author":"Brown","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0130","first-page":"1609","article-title":"Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expression","volume":"27","author":"Lindstr\u00f6m","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/dc.21270","article-title":"Functional biomarkers in cervical precancer: an overview","volume":"38","author":"Gupta","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1937-6448(08)01202-1","article-title":"Cellular and molecular biological aspects of cervical intraepithelial neoplasia","volume":"271","author":"Kisseljov","year":"2008","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.ygyno.2011.04.049_bb0145","first-page":"1","article-title":"The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy","volume":"22","author":"Taniguchi","year":"2009","journal-title":"Jpn Soc Immunol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811003507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811003507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T19:32:35Z","timestamp":1712518355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811003507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0090825811003507"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.049","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}